0

Journal Articles

in Bacterial Infections
 21-40 of 754 Articles
Medical News and Perspectives |  March 20, 2013
South Africa Warns of Emergence of “Totally” Drug-Resistant Tuberculosis
Anita Slomski
JAMA. 2013;309(11):1097-1098. doi:10.1001/jama.2013.1802.
From the Centers for Disease Control and Prevention |  March 20, 2013 FREE
Serogroup A Meningococcal Conjugate Vaccine Coverage After the First National Mass Immunization Campaign—Burkina Faso, 2011
JAMA. 2013;309(11):1104-1106. doi:10.1001/jama.2013.225.
From the Centers for Disease Control and Prevention |  March 13, 2013
Noninfluenza Vaccination Coverage Among Adults—United States, 2011
JAMA. 2013;309(10):974-979. doi:10.1001/jama.2013.1521.
Lab Reports |  March 06, 2013
How TB Bacteria Hide Out
Tracy Hampton, PhD
JAMA. 2013;309(9):865. doi:10.1001/jama.2013.1314.
Lab Reports |  March 06, 2013
Blue Light for Skin Infections
Tracy Hampton, PhD
JAMA. 2013;309(9):865. doi:10.1001/jama.2013.1846.
JAMA Patient Page |  March 06, 2013 FREE
Tuberculosis
Ann R. Punnoose, MD; Cassio Lynm, MA; Robert M. Golub, MD
JAMA. 2013;309(9):938. doi:10.1001/2012.jama.10804.
INCLUDES: , Supplemental Content
JAMA Clinical Evidence Synopsis |  February 20, 2013
Clinical Outcomes Associated With Procalcitonin Algorithms to Guide Antibiotic Therapy in Respiratory Tract Infections
Philipp Schuetz, MD, MPH; Matthias Briel, MD, MSc; Beat Mueller, MD
JAMA. 2013;309(7):717-718. doi:10.1001/jama.2013.697.
From the Centers for Disease Control and Prevention |  February 20, 2013
Notes from the Field: National Shortage of Isoniazid 300 mg Tablets
JAMA. 2013;309(7):653. doi:10.1001/jama.2013.223.
Editorial |  February 13, 2013
Antibiotics for Skin Infections:  New Study Design and a Step Toward Shorter Course Therapy
Shira Doron, MD; Helen W. Boucher, MD
JAMA. 2013;309(6):609-611. doi:10.1001/jama.2013.604.
Medical News and Perspectives |  February 13, 2013
Indian Public Health Leaders Move to Reduce Antimicrobial Resistance
Mike Mitka, MSJ
JAMA. 2013;309(6):531-532. doi:10.1001/jama.2013.297.
Original Contribution |  February 13, 2013
Tedizolid Phosphate vs Linezolid for Treatment of Acute Bacterial Skin and Skin Structure Infections:  The ESTABLISH-1 Randomized Trial
Philippe Prokocimer, MD; Carisa De Anda, PharmD; Edward Fang, MD; et al.
JAMA. 2013;309(6):559-569. doi:10.1001/jama.2013.241.
INCLUDES: , Supplemental Content
Original Contribution |  February 13, 2013
Risk of Recurrent Helicobacter pylori Infection 1 Year After Initial Eradication Therapy in 7 Latin American Communities
Douglas R. Morgan, MD, MPH; Javier Torres, PhD; Rachael Sexton, MS; et al.
JAMA. 2013;309(6):578-586. doi:10.1001/jama.2013.311.
INCLUDES: , Supplemental Content
Medical News and Perspectives |  February 06, 2013
MDR-TB Has New Drug Foe After Fast-Track Approval
Rebecca Voelker, MSJ
JAMA. 2013;309(5):430. doi:10.1001/jama.2013.94.
Grand Rounds |  January 16, 2013
Bacterial Coinfection in Influenza:  A Grand Rounds Review
Daniel S. Chertow, MD, MPH; Matthew J. Memoli, MD, MS
JAMA. 2013;309(3):275-282. doi:10.1001/jama.2012.194139.
INCLUDES: CME
Editorial |  January 09, 2013
Cephalosporin-Resistant Gonorrhea in North America
Robert D. Kirkcaldy, MD, MPH; Gail A. Bolan, MD; Judith N. Wasserheit, MD, MPH
JAMA. 2013;309(2):185-187. doi:10.1001/jama.2012.205107.
Medical News and Perspectives |  January 09, 2013
Emerging Tick-borne Diseases Expand Range Along With Rebounding Deer Populations
Bridget M. Kuehn, MSJ
JAMA. 2013;309(2):124-125. doi:10.1001/jama.2012.116881.
Preliminary Communication |  January 09, 2013
Neisseria gonorrhoeae Treatment Failure and Susceptibility to Cefixime in Toronto, Canada
Vanessa G. Allen, MD, MPH; Leo Mitterni; Christine Seah, MLT; et al.
JAMA. 2013;309(2):163-170. doi:10.1001/jama.2012.176575.
JAMA Patient Page |  January 09, 2013 FREE
Gonorrhea
Janet M. Torpy, MD; Cassio Lynm, MA; Robert M. Golub, MD
JAMA. 2013;309(2):196. doi:10.1001/2012.jama.10802.
INCLUDES: , Supplemental Content
Medical News and Perspectives |  December 26, 2012 FREE
Unsafe Injection Practices Plague US Outpatient Facilities, Harm Patients
Bridget M. Kuehn, MSJ
JAMA. 2012;308(24):2551-2552. doi:10.1001/jama.2012.114239.
Lab Reports |  December 12, 2012
Eradicating C difficile
Tracy Hampton, PhD
JAMA. 2012;308(22):2326. doi:10.1001/jama.2012.111751.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Otolaryngology–Head & Neck Surgery
Original Article  |  May 16, 2013
Disinfection of Rigid Nasal Endoscopes Following In Vitro Contamination With Staphylococcus aureus, Streptococcus pneumoniae, Pseudomonas aeruginosa, and Haemophilus influenzae
Benjamin D. Bradford, MD; Kristin A. Seiberling, MD; Francine E. Park, BS; et al.
JAMA Internal Medicine
Research Letters  |  May 13, 2013
Adult Mortality in a Randomized Trial of Mass Azithromycin for Trachoma
Jeremy D. Keenan, MD, MPH; Paul M. Emerson, PhD; Bruce D. Gaynor, MD; et al.
JAMA Dermatology
Observation  |  May 8, 2013
Anti–Laminin-332 Mucous Membrane Pemphigoid Developing After a Diphtheria Tetanus Vaccination
Tanya Sezin, MSc; Ella Egozi, MD; Wissam Hillou, MD; et al.
JAMA Internal Medicine
Original Investigation  |  March 18, 2013
Prolonged Antibiotic Treatment in Long-term Care:  Role of the Prescriber
Nick Daneman, MD, MSc; Andrea Gruneir, PhD; Susan E. Bronskill, PhD; et al.
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems